Boston Scientific (BSX) Tops Q2 EPS by 2c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Boston Scientific (BSX) PT Raised to $120 at BofA Securities
July 23, 2025 12:19 PM EDTBofA Securities analyst Travis Steed raised the price target on Boston Scientific (NYSE: BSX) to $120.00 (from $115.00) while maintaining a Buy rating.
The analyst comments "The adjusted income statement had a $100m impact in Q2 with the majority of this being inventory... More
